LIMITED-STAGE SMALL CELL LUNG CANCER (LS-SCLC)
Clinical trials for LIMITED-STAGE SMALL CELL LUNG CANCER (LS-SCLC) explained in plain language.
Never miss a new study
Get alerted when new LIMITED-STAGE SMALL CELL LUNG CANCER (LS-SCLC) trials appear
Sign up with your email to follow new studies for LIMITED-STAGE SMALL CELL LUNG CANCER (LS-SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new cocktail aims to shrink lung tumors
Disease control Not yet recruitingThis study tests a new combination of drugs and radiation as a first treatment for people with limited-stage small cell lung cancer (LS-SCLC) that cannot be removed by surgery. The treatment includes an immunotherapy (benmelstobart), a drug that cuts off tumor blood supply (anlot…
Matched conditions: LIMITED-STAGE SMALL CELL LUNG CANCER (LS-SCLC)
Phase: PHASE2 • Sponsor: Yayi He • Aim: Disease control
Last updated May 17, 2026 05:48 UTC
-
New drug cocktail aims to keep lung cancer at bay
Disease control Not yet recruitingThis study tests whether combining two drugs, tislelizumab and nintedanib, can help control limited-stage small cell lung cancer after standard chemoradiation. About 20 adults with this cancer will receive the drug combination as a follow-up treatment. The goal is to see if it de…
Matched conditions: LIMITED-STAGE SMALL CELL LUNG CANCER (LS-SCLC)
Phase: PHASE4 • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated May 15, 2026 11:58 UTC